Lung Immune Defences in the Immunosuppressed Patient

Pulmonary Infection in the Immunocompromised Patient: Strategies for Management

Volumn , Issue , 2009, Pages 1-28

  Patel, Naimish ^a   Koziel, Henry ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Barrier and pharmacological defences and innate immune and adaptive immune systems; Host defence function in select immunocompromised patients; Immunodeficiency and collagen vascular disease; Innate immunity in lungs; Lung immune defences in immunosuppressed patient; Lungs and adaptive immunity; Neutrophil function abnormalities in HIV infected individuals; Secreted antimicrobial factors in airways

Indexed keywords

EID: 84889379724     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470714171.ch1     Document Type: Chapter

References (183)

1. Abratt, R.P., Morgan, G.W., Silvestri, G. and Willcox, P. (2004) Pulmonary complications of radiation therapy. Clinics in Chest Medicine, 25, 167-177.
2. Aggarwal, B.B. (2003) Signaling pathways of the TNF superfamily: A double-edged sword. Nature Reviews Immunology, 3, 745-756.
3. Algood, H.M., Lin, P.L. and Flynn, J.L. (2005) Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clinical Infectious Diseases, 41 (Suppl 3), S189-S193.
4. Arbour, N.C., Lorenz, E., Schutte, B.C. et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genetics, 25, 187-191.
5. Armstrong, L., Medford, A.R.L., Uppington, K.M. et al. (2004) Expression of functional Toll-like receptor (TLR-)2 and TLR-4 on alveolar epithelial cells. American Journal of Respiratory Cell and Molecular Biology, (E-published March 25, 2004).
6. Au, W.Y., Ho, J.C., Lie, A.K. et al. (2001) Respiratory ciliary function in bone marrow recipients. Bone Marrow Transplantation, 27, 1147-1151.
7. Auphan, N., Didonato, J.A., Rosette, C. et al. (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappaB activity through induction of I kappa B synthesis. Science, 270, 286-290.
8. Ballet, J.J., Sulcebe, G., Couderc, L.J. et al. (1987) Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clinical and Experimental Immunology, 68, 479-487.
9. Banchereau, J. and Pascual, V. (2006) Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity, 25, 383-392.
10. Barton, G.M. and Medzhitov, R. (2003) Toll-like receptor signaling pathways. Science, 300, 1524-1525.
11. Beharka, A.A., Gaynor, C.D., Kang, B.K. et al. (2002) Pulmonary surfactant A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. Journal of Immunology, 169, 3565-3573.
12. Beiras-Fernandez, A., Thein, E. and Hammer, C. (2003) Induction of immunosuppression with polyclonal antithymocyte globulins: an overview. Experimental and Clinical Transplantation, 1, 79-84.
13. Benito, J.M., Lopez, M. and Soriano, V. (2004) The role of CD8+ T-cell response in HIV infection. AIDS Reviews, 6, 79-88.
14. Beutler, B. (2000) Tlr4: central component of the sole mammalian LPS sensor. Current Opinion in Immunology, 12, 20-26.
15. Biron, C.A., Nguyen, K.B., Pien, G.C. et al. (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annual Review of Immunology, 17, 189-220.
16. Blijlevens, N.M., Donnelly, J.P. and De Pauw, B.E. (2005) Microbiologic consequences of new approaches to managing hematologic malignancies. Reviews in Clinical & Experimental Hematology, 9, E2.
17. Borron, P., Mcintosh, J.C., Korfhagen, T.R. et al. (2000) Surfactant-associated protein A inhibits LPS-induced cytokines and nitric oxide production in vivo. American Journal of Physiology. Lung Cellular and Molecular Physiology, 278, 840-847.
18. Bowdish, D.M.E., Loffredo, M.S., Mukhopadhyay, S. et al. (2007) Macrophage receptors implicated in the 'adaptive' form of immunity. Microbes and Infection/Institut Pasteur, 9, 1680-1687.
19. Branger, J., Knapp, S., Weijer, S. et al. (2004) Role of toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice. Infection and Immunity, 72, 788-794.
20. Breen, R.A., Janossy, G., Barry, S.M. et al. (2006) Detection of mycobacterial antigen responses in lung but not blood in HIV-tuberculosis co-infected subjects. AIDS, 20, 1330-1332.
21. Brenchley, J.M., Hill, B.J., Ambrozak, D.R. et al. (2004) T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. Journal of Virology, 78, 1160-1168.
22. Brenchley, J.M., Price, D.A. and Douek, D.C. (2006) HIV disease: fallout from a mucosal catastrophe? Nature Immunology, 7, 235-239.
23. Bronke, C., Palmer, N.M., Jansen, C.A. et al. (2005) Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. The Journal of Infectious Diseases, 191, 873-880.
24. Cannon, G.W. (1997) Methotrexate pulmonary toxicity. Rheumatic Disease Clinics of North America, 23, 917-937.
25. Centlivre, M., Sala, M., Wain-Hobson, S. and Berkhout, B. (2007) In HIV-1 pathogenesis the die is cast during primary infection. AIDS, 21, 1-11.
26. Chatenoud, L. (2003) CD3-specific antibody-induced active tolerance: from bench to bedside. Nature Reviews Immunology, 3, 123-132.
27. Chatenoud, L. and Bluestone, J.A. (2007) CD3-specific antibodies: a portal to the treatment of autoimmunity. Nature Reviews Immunology, 7, 622-632.
28. Christin, L., Wysong, D.R., Meshulam, T. et al. (1998) Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infection and Immunity, 66, 1181-1189.
29. Chun, J., Soong, G. and Prince, A. (2006) Activation of Ca2+-dependent signaling by TLR2. Journal of Immunology, 177, 1330-1337.
30. Church, D., Elsayed, S., Reid, O. et al. (2006) Burn wound infections. Clinical Microbiology Reviews, 19, 403-434.
31. Clark, A.R. (2003) MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? The Journal of Endocrinology, 178, 5-12.
32. Clark, I.A. (2007) How TNF was recognized as a key mechanism of disease. Cytokine & Growth Factor Reviews, 18, 335-343.
33. Conge, A.M., Tarte, K., Reynes, J. et al. (1998) Impairment of B-lymphocyte differentiation induced by dual triggering of the B-cell antigen receptor and CD40 in advanced HIV-1-disease. AIDS, 12, 1437-1449.
34. Critchley-Thorne, R.J., Yan, N., Nacu, S. et al. (2007) Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma. PLoS Medicine, 4, e176.
35. Crouch, E.C. (1998) Collectins and pulmonary host defense. American Journal of Respiratory Cell and Molecular Biology, 19, 177-201.
36. Crowther, J.E., Kutala, V.K., Kuppusamy, P.K. et al. (2004) Pulmonary surfactant protein A inhibits macrophage reactive oxygen intermediate production in response to stimuli reducing MADPH oxidase activity. Journal of Immunology, 172, 6866-6874.
37. Cupps, T. and Fauci, A. (1982) Corticosteroid-mediated immunoregulation in man. Immunological Reviews, 65, 133-155.
38. D'Orsogna, L.J., Krueger, R.G., Mckinnon, E.J. and French, M.A. (2007) Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy. AIDS, 21, 1747-1752.
39. Day, R.B., Wang, Y., Knox, K.S. et al. (2004) Alveolar macrophages from HIV-infected subjects are resistant to Mycobacterium tuberculosis in vitro. American Journal of Respiratory Cell and Molecular Biology, 30, 403-410.
40. De Milito, A. (2004) B lymphocyte dysfunctions in HIV infection. Current HIV Research, 2, 11-21.
41. Dentener, M.A., Vreugdenhil, A.C., Hoet, P.H. et al. (2000) Production of acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. American Journal of Respiratory Cell and Molecular Biology, 23, 146-153.
42. Diamond, G., Legarda, D. and Ryan, L.K. (2000) The innate immune response of the respiratory epithelium. Immunological Reviews, 173, 27-38.
43. Douek, D.C., Picker, L.J. and Koup, R.A. (2003) T cell dynamics in HIV-1 infection. Annual Review of Immunology, 21, 265-304.
44. Duncan, M.D. and Wilkes, D.S. (2005) Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Proceedings of the American Thoracic Society, 2, 449-455.
45. Eagan, R., Twigg, H.L., 3rd, French, N. et al. (2007) Lung fluid immunoglobulin from HIV-infected subjects has impaired opsonic function against pneumococci. Clinical Infectious Diseases, 44, 1632-1638.
46. Easton, J.B. and Houghton, PJ. (2006) mTOR and cancer therapy. Oncogene, 25, 6436-6446.
47. Elbim, C., Prevot, M.H., Bouscarat, F. et al. (1994) Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding, and an impaired oxidative burst after cytokine priming. Blood, 84, 2759-2766.
48. Elgert, K.D., Alleva, D.G. and Mullins, D.W. (1998) Tumor-induced immune dysfunction: the macrophage connection. Journal of Leukocyte Biology, 64, 275-290.
49. Ellis, M., Gupta, S., Galant, S. et al. (1988) Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. The Journal of Infectious Diseases, 158, 1268-1276.
50. Elssner, A., Carter, J.E., Yunger, T.M. and Wewers, M.D. (2004) HIV-1 infection does not impair human alveolar macrophage phagocytic function unless combined with cigarette smoking. Chest, 125, 1071-1076.
51. Fahy, R.J., Diaz, P.T., Hart, J. and Wewers, M.D. (2001) BAL and serum IgG levels in healthy asymptomatic HIV-infected patients. Chest, 119, 196-203.
52. Fauci, A.S. (1988) The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science, 239(4840), 617-622.
53. Feldmesser, M. (2006) Role of neutrophils in invasive aspergillosis. Infection and Immunity, 74, 6514-6516.
54. Genestier, L., Paillot, R., Quemeneur, L. et al. (2000) Mechanisms of action of methotrexate. Immunopharmacology, 47', 247-257.
55. Gordon, S.B., Molyneux, M.E., Boeree, M.J. et al. (2001) Opsonic phagocytosis of Streptococcus pneumoniae by alveolar macrophages is not impaired in human immunodeficiency virus-infected Malawian adults. The Journal of Infectious Diseases, 184, 1345-1349.
56. Granelli-Piperno, A., Delgado, E., Finkel, V. et al. (1998) Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M-and T-tropic virus to T cells. Journal of Virology, 72, 2733-2737.
57. Granelli-Piperno, A., Golebiowska, A., Trumpfheller, C. et al. (2004) HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proceedings ofthe National Academy ofSciences ofthe United States ofAmerica, 101, 7669-7674.
58. Granelli-Piperno, A., Shimeliovich, I., Pack, M. et al. (2006) HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. Journal of Immunology, 176, 991-998.
59. Guadalupe, M., Reay, E., Sankaran, S. et al. (2003) Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. Journal of Virology, 77, 11708-11717.
60. Gummert, J.F., Ikonen, T. and Morris, R.E. (1999) Newer immunosuppressive drugs: a review. Journal of the American Society of Nephrology, 10, 1366-1380.
61. Haberal, M., Emiroglu, R., Dalgic, A. et al. (2004) The impact of cyclosporine on the development of immunosuppressive therapy. Transplantation Proceedings, 36, 143S-147.
62. Haidinger, M., Geyeregger, R., Poglitsch, M. et al. (2007) Antithymocyte globulin impairs T-cell/ antigen-presenting cell interaction: disruption of immunological synapse and conjugate formation. Transplantation, 84, 117-121.
63. Hale, G., Xia, M.Q., Tighe, H.P., Dyer, M.J. and Waldmann, H. (1990) The CAMPATH-1 antigen (CDw52). Tissue Antigens, 35(3), 118-127.
64. Hamadani, M., Benson, D.M., Jr, Blum, W. et al. (2007) Pulmonary Nocardia and Aspergillus co-infection in a patient with chronic graft-versus-host disease. Transplant Infectious Disease.
65. Hamilton, C.D. (2005) Immunosuppression related to collagen-vascular disease or its treatment. Proceedings of the American Thoracic Society, 2, 456-460.
66. Hart, M., Steel, A., Clark, S.A. et al. (2007) Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. Journal of Immunology, 178, 8212-8220.
67. Hartmann, A., Sagedal, S. and Hjelmesaeth, J. (2006) The natural course of cytomegalovirus infection and disease in renal transplant recipients. Transplantation, 82, S15-S17.
68. Hawn, T.R., Verbon, A., Lettinga, K.D. et al. (2003) A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. The Journal of Experimental Medicine, 198, 1563-1572.
69. Heitman, J., Movva, N.R. and Hall, M.N. (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science, 253, 905-909.
70. Higenbottam, T., Kuwano, K., Nemery, B. and Fujita, Y. (2004) Understanding the mechanisms of drug-associated interstitial lung disease. British Journal of Cancer, 91 (Suppl 2), S31-S37.
71. Hiratsuka, T. and Al, E. (1998) Identification of human b-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochemical and Biophysical Research Communications, 249, 943-947.
72. Ho, S., Clipstone, N., Timmermann, L. et al. (1996) The mechanism of action of cyclosporin A and FK506. Clinical Immunology and Immunopathology, 80, S40-S45.
73. Hotchkiss, R.S., Tinsley, K.W. Swanson, P.E. et al. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. Journal of Immunology, 166, 6952-6963.
74. Hubel, K., Hegener, K., Schnell, R. et al. (1999) Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia. Annals of Hematology, 78, 73-77.
75. Imler, J.L. and Hossmann, J.A. (2001) Toll receptors in innate immunity. Trends in Cell Biology, 11, 304-311.
76. Ingle, G.R., Sievers, T.M. and Holt, C.D. (2000) Sirolimus: continuing the evolution of transplant immunosuppression. Annals of Pharmacotherapy, 34, 1044-1055.
77. Jia, H.P., Kline, J.N., Penisten, A. et al. (2004) Endotoxin responsiveness of human airway epithelia is limited by low expression of MD-2. American Journal of Physiology. Lung Cellular and Molecular Physiology, 287, 428-437.
78. Jonat, C., Rahmsdorf, H.J., Park, K.K. et al. (1990) Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell, 62, 1189-1204.
79. Jones, B.W., Heldwein, K.A., Means, T.K. et al. (2001) Differential roles of toll-like receptors in the elicitation of proinflammatory responses by macrophages. Annals of the Rheumatic Diseases, 60 (supplement), 6-12.
80. Joos, L. and Tamm, M. (2005) Breakdown of pulmonary host defense in the immunocompromised host: cancer chemotherapy. Proceedings of the American Thoracic Society, 2, 445-448.
81. Kahan, B.D. (1989) Cyclosporine. The New England Journal of Medicine, 321, 1725-1738.
82. Kajikawa, O., Frevert, C.W., Lin, S.M. et al. (2005) Gene expression of Toll-like receptor 2. Toll-like receptor 4 and MD2 is differentially regulated in, rabbits with Escherichia coli pneumonia. Gene, 344, 193-202.
83. Kapturczak, M.H., Meier-Kriesche, H.U. and Kaplan, B. (2004) Pharmacology of calcineurin antagonists. Transplantation Proceedings, 36, 25S-32.
84. Kiessling, R., Wasserman, K., Horiguchi, S. et al. (1999) Tumor-induced immune dysfunction. Cancer Immunology, Immunotherapy, 48, 353-362.
85. Kim, K.D., Zhao, J., Auh, S. et al. (2007) Adaptive immune cells temper initial innate responses. Nature Medicine, 13, 1248-1252.
86. King-Biggs, M.B., Dunitz, J.M., Park, S.J. et al. (2003) Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. Transplantation, 75, 1437-1443.
87. Kitchen, S.G., Korin, Y.D., Roth, M.D. et al. (1998) Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. Journal of Virology, 72, 9054-9060.
88. Knight, S.C., Patterson, S. and Macatonia, S.E. (1991) Stimulatory and suppressive effects of infection of dendritic cells with HIV-1. Immunology Letters, 30, 213-218.
89. Kotloff, R.M., Ahya, V.N. and Crawford, S.W. (2004) Pulmonary complications of solid organ and hematopoietic stem cell transplantation. American Journal of Respiratory and Critical Care Medicine, 170, 22-48.
90. Koziel, M.J. (2006) Influence of HIV co-infection on hepatitis C immunopathogenesis. Journal of Hepatology, 44, S14-S18.
91. Koziel, H., Kim, S., Reardon, C., Li, X., Garland, R., Pinkston, P.et al. (1999) Enhancedinvivohuman immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. American Journal of Respiratory and Critical Care Medicine, 160(6), 2048-2055.
92. Koziel, H., Eichbaum, Q., Kruskal, B.A. et al. (1998) Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. The Journal of Clinical Investigation, 102, 1332-1344.
93. Koziel, H., Li, X., Armstrong, M.Y. et al. (2000) Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro. American Journal of Respiratory Cell and Molecular Biology, 23, 452-459.
94. Kuritzkes, D.R. (2000) Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor. Clinical Infectious Diseases, 30, 256-260.
95. Kyttaris, V.C. and Tsokos, G.C. (2004) T lymphocytes in systemic lupus erythematosus: an update. Current Opinion in Rheumatology, 16, 548-552.
96. Lane, H.C., Masur, H., Edgar, L.C. et al. (1983) Abnormalities of B-cell activation and immunoregu-lation in patients with the acquired immunodeficiency syndrome. The New England Journal of Medicine, 309, 453-458.
97. Lang, W., Perkins, H., Anderson, R.E. et al. (1989) Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. Journal of Acquired Immune Deficiency Syndromes, 2, 63-69.
98. Laurent, A.F., Dumont, S., Poindron, P. and Muller, C.D. (1996) Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endothelial cells and to some substrates. Experimental Hematology, 24, 59-67.
99. Ledergerber, B., Egger, M., Erard, V. et al. (1999) AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. Journal of the American Medical Association, 282, 2220-2226.
100. Lee, Y.R., Yang, I.H., Lee, Y.H. et al. (2005) Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. Blood, 105, 3951-3955.
101. Liew, F.Y., Xu, D., Brint, E.K. and O'Neill, L.A.J. (2005) Negative regulation of Toll-like receptor-mediated immune responses. Nature Reviews Immunology, 5, 446-458.
102. Lindenfeld, J., Miller, G.G., Shakar, S.F. et al. (2004) Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Circulation, 110, 3734-3740.
103. Livingstone, W.J., Moore, M., Innes, D. et al. (1996) Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group. Lancet, 348, 649-654.
104. Lore, K., Sonnerborg, A., Brostrom, C. et al. (2002) Accumulation of DC-SIGN+ CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS, 16, 683-692.
105. Macatonia, S.E., Lau, R., Patterson, S. et al. (1990) Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology, 71, 38-45.
106. Magliocca, J.F. and Knechtle, S.J. (2006) The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transplant International, 19, 705-714.
107. Malaspina, A., Moir, S., Kottilil, S. et al. (2003) Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. Journal of Immunology, 170, 5965-5972.
108. Malik, S.W., Myers, J.L., Deremee, R.A. and Specks, U. (1996) Lung toxicity associated with cyclophosphamide use. Two distinct patterns. American Journal of Respiratory and Critical Care Medicine, 154, 1851-1856.
109. Margolick, J.B., Donnenberg, A.D., Munoz, A. et al. (1993) Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3-populations suggest regulatory responses linked to loss of CD4 lymphocytes. The multicenter AIDS cohort study. Journal of Acquired Immune Deficiency Syndromes, 6, 153-161.
110. Martin, T.R. and Frevert, C.W. (2005) Innate immunity in the lungs. Proceedings of the American Thoracic Society, 2, 403-411.
111. Martin, T.R., Mathison, J.C., Tobias, P.S. et al. (1992) Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide: implications for cytokine production in normal and injured lungs. The Journal of Clinical Investigation, 90, 2209-2219.
112. Martin, F., Lauwerys, B., Lefebvre, C. et al. (1997a) Side-effects of intravenous cyclophosphamide pulse therapy. Lupus, 6, 254-257.
113. Martin, T.R., Rubenfeld, G.D., Ruzinski, J.T. et al. (1997b) Relationship between soluble CD14, lipo-polysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine, 155, 937-944.
114. Matsuda, S., Shibasaki, F., Takehana, K. et al. (2000) Two distinct action mechanisms of immuno-philin-ligand complexes for the blockade of T-cell activation. EMBO Reports, 1, 428-434.
115. Mccormack, F.X. and Whitsett, J.A. (2002) The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. The Journal of Clinical Investigation, 109, 707-712.
116. McCray, P.B. and Bentley, L. (1997) Human airway epithelia express a defensin. American Journal of Respiratory Cell and Molecular Biology, 16, 343-349.
117. Meddows-Taylor, S., Martin, D.J. and Tiemessen, C.T. (1998) Reduced expression of interleukin-8 receptors A and B on polymorphonuclear neutrophils from persons with human immunodeficiency virus type 1 disease and pulmonary tuberculosis. The Journal of Infectious Diseases, 177, 921-930.
118. Meddows-Taylor, S., Pendle, S. and Tiemessen, C.T. (2001) Altered expression of CD88 and associated impairment of complement 5a-induced neutrophil responses in human immunodeficiency virus type 1-infected patients with and without pulmonary tuberculosis. The Journal of Infectious Diseases, 183, 662-665.
119. Medzhitov, R. (2001) Toll-like receptors and innate immunity. Nature Reviews Immunology, 1, 135-145.
120. Mohty, M. (2007) Mechanisms of action of antithymocyte globul: T-cell depletion and beyond. Leukemia, 21, 1387-1394.
121. Monari, C., Casadevall, A., Pietrella, D. et al. (1999) Neutrophils from patients with advanced human immunodeficiency virus infection have impaired complement receptor function and preserved Fcgamma receptor function. The Journal of Infectious Diseases, 180, 1542-1549.
122. Monneret, G., Debard, A.L., Venet, F. et al. (2003) Marked elevation of human circulating CD4+ CD25+ regulatory T cells in sepsis-induced immunoparalysis. Critical Care Medicine, 31, 2068-2071.
123. Morand, E.F. (2007) Effects of glucocorticoids on inflammation and arthritis. Current Opinion in Rheumatology, 19, 302-307.
124. Morris, L., Binley, J.M., Clas, B.A. et al. (1998) HIV-1 antigen-specific and-nonspecific B cell responses are sensitive to combination antiretroviral therapy. The Journal of Experimental Medicine, 188, 233-245.
125. Muro-Cacho, C.A., Pantaleo, G. and Fauci, A.S. (1995) Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of, activation of the lymphoid tissue and not with stage of disease or viral burden. Journal of Immunology, 154, 5555-5566.
126. Murray, H.W., Hillman, J.K., Rubin, B.Y. et al. (1985) Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon, production. The New England Journal of Medicine, 313, 1504-1510.
127. Muzio, M., Bosisio, D., Polentarutti, N. et al. (2000) Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. Journal of Immunology, 164, 5998-6004.
128. Noel, V., Lortholary, O., Casassus, P. et al. (2001) Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Annals of the Rheumatic Diseases, 60, 1141-1144.
129. Notermans, D.W., De Jong, J.J., Goudsmit, J. et al. (2001) Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses. AIDS Research and Human Retroviruses, 17, 1003-1008.
130. Oliner, H., Schwartz, R., Rubio, F. and Dameshek, W. (1961) Interstitial pulmonary fibrosis following busulfan therapy. The American Journal of Medicine, 31, 134-139.
131. Orenstein, J.M., Fox, C. and Wahl, S.M. (1997) Macrophages as a source of HIV during opportunistic infections. Science, 276(5320), 1857-1861.
132. Organization, W.H. (2007) TB and HIV/AIDS. 2007 Tuberculosis Facts Sheet, 1-2.
133. Patel, N.R., Zhu, J., Tachado, S.D. et al. (2007) HIV impairs TNF-alpha mediated macrophage apoptotic response to Mycobacterium tuberculosis. Journal of Immunology, 179, 6973-6980.
134. Plosker, G.L. and Figgitt, D.P. (2003) Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs, 63, 803-843.
135. Ponticelli, C. (2006) New therapies for lupus nephritis. Clinical Journal of the American Society of Nephrology, 1, 863-868.
136. Potena, L. and Valantine, H.A. (2007) Cytomegalovirus-associated allograft rejection in heart transplant patients. Current Opinion in Infectious Diseases, 20, 425-431.
137. Prevention, CFDCA, (2006) HIV/AIDS Surveillance Report, 2006. HIV/AIDS Surveillance Report, 18, 1-55.
138. Quemeneur, L., Beloeil, L., Michallet, M.C. et al. (2004) Restriction of de novo nucleotide biosynthesis interferes with clonal expansion and differentiation into effector and memory CD8 T cells. Journal of Immunology, 173, 4945-4952.
139. Renders, L. and Valerius, T. (2003) Engineered CD3 antibodies for immunosuppression. Clinical and Experimental Immunology, 133, 307-309.
140. Rodriguez-Barradas, M.C., Musher, D.M., Lahart, C. et al. (1992) Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. The Journal of Infectious Diseases, 165, 553-556.
141. Rothlin, C.V., Ghosh, S., Zuniga, E.I. et al. (2007) TAM receptors are pleotropic inhibitors of the innate immune response. Cell, 131, 1124-1136.
142. Saba, T.M., Blumenstock, F.A., Shah, D.M. et al. (1986) Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Correlation with experimental observations. The American Journal of Medicine, 80, 229-240.
143. Sachse, C., Prigge, M., Cramer, G. et al. (1999) Association between reduced human leukocyte antigen (HLA)-DR expression on blood monocytes and increased plasma level of interleukin-10 in patients with severe burns. Clinical Chemistry and Laboratory Medicine, 37, 193-198.
144. Sano, H., Chiba, H., Iwaki, D. et al. (2000) Surfactant proteins A and D bind CD14 by different mechanisms. The Journal of Biological Chemistry, 275, 22442-22451.
145. Saukkonen, J.J., Bazydlo, B., Thomas, M. et al. (2002) Beta chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infection and Immunity, 70, 1684-1693.
146. Schluger, N.W., Perez, D. and Liu, Y.M. (2002) Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy. Chest, 122, 597-602.
147. Scrivener, S., Goddard, R.V., Kaminski, E.R. and Prentice, A.G. (2003) Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leukemia & Lymphoma, 44, 383-389.
148. Shearer, G.M., Salahuddin, S.Z., Markham, P.D. et al. (1985) Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. The Journal of Clinical Investigation, 76, 1699-1704.
149. Shepherd, V.L. (2002) Distinct roles for lung collectins in pulmonary host defense. American Journal of Respiratory Cell and Molecular Biology, 26, 257-260.
150. Sheridan, J.F., Aurelian, L., Donnenberg, A.D. and Quinn, T.C. (1984) Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses. Journal of Clinical Immunology, 4, 304-311.
151. Shirai, A., Cosentino, M., Leitman-Klinman, S.F. and Klinman, D.M. (1992) Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. The Journal of Clinical Investigation, 89, 561-566.
152. Sintchak, M.D., Fleming, M.A., Futer, O., Raybuck, S.A, Chambers, S.P., Caron, P.R. et al. (1996) Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell, 85(6), 921-930.
153. Skerrett, S.J., Liggitt, H.D., Hajjar, A.M. et al. (2004) Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. American Journal ofPhysiology. Lung Cellular and Molecular Physiology, 287, 143-152.
154. Sleijfer, S. (2001) Bleomycin-induced pneumonitis. Chest, 120, 617-624.
155. Soong, G., Reddy, B., Sokol, S. et al. (2004) TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. The Journal of Clinical Investigation, 113, 1482-1489.
156. Stebbing, J., Gazzard, B. and Douek, D.C. (2004) Where does HIV live? The New England Journal of Medicine, 350(18), 1872-1880.
157. Sutherland, R., Yang, H., Scriba, TJ. et al. (2006) Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART. AIDS, 20, 821-829.
158. Tachado, S.D., Zhang, J., Zhu, J. et al. (2005) HIV impairs TNF-alpha release in response to TLR4 stimulation in human alveolar macrophages in vitro. American Journal of Respiratory Cell and Molecular Biology, 33, 610-621.
159. Taylor, A.L., Watson, C.J. and Bradley, J.A. (2005) Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. Critical Reviews in Oncology/ Hematology, 56, 23-46.
160. Tiede, I., Fritz, G., Strand, S. et al. (2003) CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. The Journal of Clinical Investigation, 111, 1133-1145.
161. Turville, S.G., Cameron, P.U., Handley, A. et al. (2002) Diversity of receptors binding HIV on dendritic cell subsets. Nature Immunology, 3, 975-983.
162. Twigg, H.L., Soliman, D.M., Day, R.B. et al. (1999) Lymphocytic alveolitis, bronchoalveolar lavage viral load, and outcome in human immunodeficiency virus infection. American Journal of Respiratory and Critical Care Medicine, 159, 1439-1444.
163. van Wetering, S., Mannesse-Lazeroms, S.P., Van Sterkenberg, M.A. et al. (1997) Effect of defensins on interleukin-8 synthesis in airway epithelial cells. The American Journal of Physiology, 272, L888-L896.
164. Veazey, R. and Lackner, A. (2003) The mucosal immune system and HIV-1 infection. AIDS Reviews, 5, 245-252.
165. Veazey, R.S., Demaria, M., Chalifoux, L.V. et al. (1998) Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science, 280, 427-431.
166. Viscoli, C., Varnier, O. and Machetti, M. (2005) Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clinical Infectious Diseases, 40 (Suppl 4), S240-S245.
167. Waldmann, T.A. (2007) Anti-Tac (daclizumab, Zenapax) in the treatment of leukemia, autoimmune diseases, and in the prevention of allograft rejection: A 25-year personal odyssey. Journal of Clinical Immunology, 27, 1-18.
168. Wang, X., Moser, C., Louboutin, J.P. et al. (2002) Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. Journal of Immunology, 168, 810-815.
169. Watford, W.T., Ghio, A.J. and Wright, J.R. (2000) Complement-mediated host defense in the lung. American Journal of Physiology. Lung Cellular and Molecular Physiology, 279, 790-798.
170. Wessely, R., Schomig, A. and Kastrati, A. (2006) Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. Journal of the American College of Cardiology, 47, 708-714.
171. Wolk, K., Docke, W., von Baehr, V. et al. (1999) Comparison of monocyte functions after LPS-or IL-10-induced reorientation: importance in clinical immunoparalysis. Pathobiology, 67, 253-256.
172. Wong, H.R., Pitt, B.R., Su, G.L. et al. (1995) Induction of lipopolysaccharide-binding protein gene expression in cultured rat pulmonary artery smooth muscle cells by interleukin 1 beta. American Journal of Respiratory Cell and Molecular Biology, 12, 449-454.
173. Wu, L. and KewalRamani, V.N. (2006) Dendritic-cell interactions with HIV: infection and viral dissemination. Nature Reviews Immunology, 6, 859-868.
174. Wunderink, R.G. (2005) Nosocomial pneumonia, including ventilator-associated pneumonia. Proceedings of the American Thoracic Society, 2, 440-444.
175. Yeaman, M.R., Puentes, S.M., Norman, D.C. and Bayer, A.S. (1992) Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infection and Immunity, 60, 1202-1209.
176. Yeaman, M.R., Soldan, S.S., Ghannoum, M.A. et al. (1996) Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infection and Immunity, 64, 1379-1384.
177. Young, K.R., Jr, Rankin, J.A., Naegel, G.P. et al. (1985) Bronchoalveolar lavage cells and proteins in patients with the acquired immunodeficiency syndrome. An immunologic analysis. Annals of Internal Medicine, 103, 522-533.
178. Zaas, A.K. and Schwartz, D.A. (2005) Innate immunity and the lung: defense at the interface between host and environment. Trends in Cardiovascular Medicine, 15, 195-202.
179. Zapata-Sirvent, R.L. and Hansbrough, J.F. (1993) Temporal analysis of human leucocyte surface antigen expression and neutrophil respiratory burst activity after thermal injury. Burns, 19, 5-11.
180. Zhang, L., Huang, Y., He, T., Cao, Y. and Ho, D.D. (1996) HIV-1 subtype and second-receptor use. Nature. 383(6603), 768.
181. Zhang, J. and Koziel, H. (2002) Alveolar macrophages, in Cellular Aspects of HIV Infection (eds A. Cossarizza and D. Kaplan), Wiley-Liss, Inc, New York.
182. Zhang, J.M., Zhu, J., Imrich, A. et al. (2004) Pneumocystis activates human alveolar macrophage NF-kB signaling through mannose receptors. Infection and Immunity, 72, 3147-3160.
183. Zhu, L.P., Cupps, T.R., Whalen, G. and Fauci, A.S. (1987) Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells. The Journal of Clinical Investigation, 79, 1082-1090.